EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes

Ebaa Al-Ozairi iD, Mohammad Irshad iD, Jumana AlKandari, Anant Mashankar, Dherar Alroudhan, Carel W le Roux iD

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Ebaa Al-Ozairi und 5 weiteren Autor:innen. Beteiligte Einrichtung: DAFNE Unit, Clinical Care Research and Clinical Trials Unit, Dasman Diabetes Institute, Kuwait City, Kuwait. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Obesity, Liver Cirrhosis, Elasticity Imaging Techniques. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kuwait Foundation for the Advancement of Sciences (KFAS), Ministry of Health, Kuwait.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To compare hepatic stiffness and fat fraction in patients with obesity and type 1 diabetes (T1D) with type 2 diabetes (T2D) with a similar body mass index (BMI).

Methods

In this prospective cross‐sectional study, 90 participants with T1D (BMI 30.5 ± 4.5 kg/m 2 ; diabetes duration 20.5 ± 9.8 years; HbA1c 8.2% ± 1.4%) and 69 with T2D (BMI: 30.8 ± 4.6 kg/m 2 ; diabetes duration: 11.7 ± 7.8 years; HbA1c: 7.3% ± 1.4%) were included. Liver fat fraction and stiffness were examined by magnetic resonance imaging and elastography, respectively. Logistic regressions were used to evaluate associations with biomedical variables.

Results

The mean liver stiffness score in patients with obesity and T1D was 2.2 ± 0.5 kPa, while in T2D it was 2.6 ± 0.8 kPa ( P < .001). The liver fat fraction in patients with obesity and T1D was 3.7% ± 6.3%, and in T2D it was 10.6% ± 7.9% ( P < .001). Metabolic dysfunction‐associated steatotic liver disease (MASLD) was present in 13.3% of patients with T1D and in 69.6% of patients with T2D, whereas fibrosis was suggested in 7.8% of patients with T1D and in 27.5% of patients with T2D. Liver stiffness was four times higher in patients with T2D compared with those with T1D (odds ratio = 5.4, 95% confidence interval: 2.1‐13.6, P < .001). Aspartate transaminase (AST), alanine transaminase, gamma‐glutamyl transferase (GGT), triglycerides and the android‐to‐gynoid ratio were associated with elevated fat fraction in both cohorts. AST and GGT were associated with elevated liver stiffness in both cohorts.

Conclusions

Patients with obesity and T1D had lower liver fat and liver stiffness compared with those patients with T2D, despite similar levels of BMI, a longer duration of diabetes and worse glycaemic control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1ObesityLiver CirrhosisElasticity Imaging TechniquesLiverDiabetes Mellitus, Type 2HumansMaleFemaleCross-Sectional StudiesMiddle AgedAdultProspective StudiesBody Mass IndexMagnetic Resonance ImagingFatty Liver

Stichwörter der Autor:innen

MASLDMREliver fat fractionliver stiffnesstype 1 diabetes

Autor:innen und Institutionen

  • DAFNE Unit, Clinical Care Research and Clinical Trials Unit, Dasman Diabetes Institute, Kuwait City, Kuwait.
  • Amiri Hospital, Ministry of Health, Kuwait City, Kuwait.
  • Diagnostic Imaging Centre, Dasman Diabetes Institute, Kuwait City, Kuwait.
  • Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.
  • Diabetes Research Centre, Ulster University, Belfast, UK.

ORCID-Profile: Ebaa Al-Ozairi, Mohammad Irshad, Carel W le Roux

Förderung

  • Kuwait Foundation for the Advancement of Sciences (KFAS)
  • Ministry of Health, Kuwait

Zitieren

APA

Al-Ozairi, E., Irshad, M., AlKandari, J., Mashankar, A., Alroudhan, D., & le Roux, C. W. (2024). Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15760

Vancouver

Al-Ozairi E, Irshad M, AlKandari J, Mashankar A, Alroudhan D, le Roux CW. Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15760

BibTeX
@article{AlOzairi2024,
  author = {Al-Ozairi, Ebaa and Irshad, Mohammad and AlKandari, Jumana and Mashankar, Anant and Alroudhan, Dherar and le Roux, Carel W},
  title = {Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15760}
}
Kostenlos starten →